Apyx Medical (NASDAQ: APYX) COO nets 4,467 shares after option exercise
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Apyx Medical Corp Chief Operating Officer Shawn David Roman reported a net stock option exercise through The Roman Family Revocable Trust. On June 15, 2026, he exercised 15,000 stock options at an exercise price of $3.23 per share.
To cover the aggregate exercise price, 10,533 shares of common stock otherwise issuable were withheld by the issuer at a value of $4.60 per share as a tax and exercise-price payment. As a result, 4,467 net shares of common stock were issued to the trust. Following the tax-withholding disposition, the trust held 16,467 shares of Apyx Medical common stock indirectly for the reporting person.
Positive
- None.
Negative
- None.
Insider Trade Summary
15,000 shares exercised/converted
Mixed
3 txns
Insider
Roman Shawn David
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock option (right to buy) | 15,000 | $0.00 | -- |
| Exercise | Common Stock | 15,000 | $3.23 | $48K |
| Tax Withholding | Common Stock | 10,533 | $4.60 | $48K |
Holdings After Transaction:
Stock option (right to buy) — 0 shares (Direct, null);
Common Stock — 15,000 shares (Indirect, By The Roman Family Revocable Trust)
Footnotes (1)
- Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary. On June 15, 2026, the Reporting Person effected a net exercise of 15,000 stock options with an exercise price of $3.23 per share. Pursuant to the terms of the exercise, 10,533 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.60 per share to satisfy the aggregate exercise price, resulting in the issuance of 4,467 net shares to the Reporting Person.
Key Figures
Options exercised: 15,000 shares
Exercise price: $3.23/share
Shares withheld: 10,533 shares
+4 more
7 metrics
Options exercised
15,000 shares
Stock options exercised on June 15, 2026 at $3.23 per share
Exercise price
$3.23/share
Exercise price of stock option (right to buy)
Shares withheld
10,533 shares
Withheld at $4.60 per share for exercise price and taxes
Withholding value per share
$4.60/share
Value used by issuer for withheld shares on June 15, 2026
Net shares issued
4,467 shares
Net common shares issued to the reporting person’s trust
Indirect holdings after transaction
16,467 shares
Apyx Medical common stock held by The Roman Family Revocable Trust
Option expiration
May 1, 2027
Expiration date of exercised stock option (right to buy)
Key Terms
stock option (right to buy), net exercise, tax-withholding disposition, derivative exercise/conversion, +1 more
5 terms
stock option (right to buy) financial
"security_title: "Stock option (right to buy)""
net exercise financial
"the Reporting Person effected a net exercise of 15,000 stock options"
tax-withholding disposition financial
"transaction_action: "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion""
Revocable Trust financial
"Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
FAQ
What insider transaction did Apyx Medical (APYX) report for COO Shawn David Roman?
Apyx Medical’s COO, Shawn David Roman, exercised 15,000 stock options at $3.23 per share. To fund the exercise and related obligations, 10,533 shares were withheld, resulting in 4,467 net shares issued to his family trust.
Was the Apyx Medical (APYX) Form 4 transaction an open-market sale?
No, the Form 4 shows a tax-withholding disposition, not an open-market sale. Shares were withheld by the issuer at $4.60 per share to pay the option exercise cost and taxes, leaving 4,467 net shares issued.
What stock option details were disclosed in the Apyx Medical (APYX) Form 4?
The filing shows exercise of 15,000 stock options with an exercise price of $3.23 per share. These options, described as a “stock option (right to buy),” had an expiration date of May 1, 2027 before being fully exercised.